If you made any changes in Pure these will be visible here soon.

Publications 2010 2018

Filter
Meeting Abstract
2017

CHRONIC MYELOID LEUKEMIA PATIENTS WERE NOT DIFFERENT IN MOLECULAR RELAPSE AFTER STOPPING IMATINIB IN MR4 WHETHER RESIDUAL DISEASE WAS DETECTED OR NOT - WHEN ADJUSTING FOR NUMBER OF CONTROL TRANSCRIPTS

Pfirrmann, M., Mahon, F-X., Guilhot, J., Richter, J., Almeida, A., Janssen, J. J., Mayer, J., Koskenvesa, P., Panayiotidis, P., Olsson-Stromberg, U., Berger, M. G., Diamond, J., Ehrencrona, H., Kairisto, V., Polakova, K. M., Mueller, M. C., Mustjoki, S., Hochhaus, A., Saussele, S. & Hjorth-Hansen, H., 26 Jun 2017, In : Haematologica. 102, p. 153-153 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

2016

CML Patients with Primary Resistance or Suboptimal Response to TKI Therapy Have Variants in Genes Affecting Drug Absorption and Metabolism

Pietarinen, P., Koskenvesa, P., Klievink, J., Porkka, K., Niemi, M. & Mustjoki, S., 2 Dec 2016, In : Blood. 128, 22, 4 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Early MRD-Negativity May Predict for Favorable Outcome Irrespective of Allotransplantation in TKI-Treated Patients with Ph-Positive Acute Lymphoblastic Leukemia

Hohtari, H., Sinisalo, M., Nousiainen, T., Koskenvesa, P., Wartiovaara-Kautto, U., Mustjoki, S., Koistinen, P., Saeily, M., Itaelae-Remes, M., Elonen, E., Remes, K. & Porkka, K., 2 Dec 2016, In : Blood. 128, 22, 5 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Effects of Dasatinib and Interferon-alpha Combination Treatment on the Immune System in CML

Ilander, M., Lahteenmaki, H., Olsson-Stromberg, U., Stentoft, J., Richter, J., Koskenvesa, P., Hoglund, M., Dreimane, A., Porkka, K., Gedde-Dahl, T., Gjertsen, B. T., Gruber, F. X., Stenke, L., Myhr-Eriksson, K., Markevarn, B., Lubking, A., Vestergaard, H., Udby, L., Bjerrum, O. W., Hjorth-Hansen, H. & 1 othersMustjoki, S., 2 Dec 2016, In : Blood. 128, 22, 5 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Immunological Monitoring of CML Patients during First-Line Bosutinib and Imatinib Treatment

Kreutzman, A., Koskenvesa, P., Tiina, K., Olsson-Stromberg, U., Stentoft, J., Stenke, L., Udby, L., Gjertsen, B. T., Lotfi, K., Markevan, B., Janssen, J., Brummendorf, T., Richter, J., Hjorth-Hansen, H. & Mustjoki, S., 2 Dec 2016, In : Blood. 128, 22, 5 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review